Takeda Pharmaceutical Co. Ltd. · TSE:4502
Weber Christophe Pierre received 244,270 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)
Traded Apr 27, 2026 · Filed Apr 28, 2026
On Apr 27, 2026, Weber Christophe Pierre (Director, President and CEO) received 244,270 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 418,803 shares. Filed Apr 28, 2026 (Form 4).
- Awarded
- 244,270 shares
- Holding after
- 418,803 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Ordinary Shares | Award | 78,900 | 1,014,200 | Direct | |
| Apr 27, 2026 | American Depositary Shares | Award | 165,370 | 418,803 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Weber Christophe Pierre
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026